Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

ENVB Enveric Biosciences Inc

0.0191 (2.22%)
最終更新日: 07:26:01
名称 銘柄コード 市場 種別
Enveric Biosciences Inc ENVB NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.0191 2.22% 0.8801 07:26:01
始値 安値 高値 終値 前日終値
0.8752 0.8558 0.899 0.8974 0.861
この銘柄の詳細情報 »


日付 時間 ソース タイトル
2024/3/2620:00BWEnveric Biosciences Reports Financial Results and Provides..
2024/3/1920:00BWEnveric Biosciences Signs Non-Binding Term Sheets to Pursue..
2024/3/1220:00BWEnveric Biosciences Announces New Patent Issuances..
2024/3/1201:35EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/3/1121:00EDGAR2Form 8-K - Current report
2024/2/2921:00EDGAR2Form 8-K - Current report
2024/2/2921:00BWEnveric Biosciences Signs Non-Binding Term Sheets to Pursue..
2024/2/2706:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2706:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2706:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2322:00BWEnveric Biosciences Agrees to Sell Cancer-Targeting..
2024/2/2122:05EDGAR2Form 8-K - Current report
2024/2/2122:00BWEnveric Biosciences Unveils Library of Preclinical Compounds..
2024/2/1505:36EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/0922:05EDGAR2Form 8-K - Current report
2024/2/0700:17EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0607:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/2422:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/1/2314:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/1/1206:43EDGAR2Form S-3 - Registration statement under Securities Act of..
2024/1/0906:42EDGAR2Form 8-K - Current report
2024/1/0322:05EDGAR2Form 8-K - Current report
2023/12/3006:43EDGAR2Form 8-K - Current report
2023/12/2922:52BWEnveric Biosciences Announces Exercise of Warrants and..
2023/12/2822:05EDGAR2Form 8-K - Current report
2023/12/2822:00BWEnveric Biosciences Selects EB-003 as Lead Drug Candidate..
2023/12/2722:05EDGAR2Form 8-K - Current report
2023/12/2722:00BWEnveric Biosciences Reports Year End Progress for..
2023/12/2022:00BWEnveric Biosciences to Participate in Biotech Showcase 2024..
2023/12/0706:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
2023/12/0522:05EDGAR2Form 8-K - Current report
2023/12/0522:00BWEnveric Biosciences Selects Development Candidates from..
2023/12/0206:31EDGAR2Form S-1/A - General form for registration of securities..
2023/11/2922:18EDGAR2Form 8-K - Current report
2023/11/2922:00BWEnveric Biosciences Receives Notice of Allowance from USPTO..
2023/11/2722:00BWEnveric Biosciences Announces Manuscript Describing the..
2023/11/2422:00BWEnveric Biosciences Announces Presentation of Two Posters at..
2023/11/2306:30EDGAR2Form 8-K - Current report
2023/11/1406:10EDGAR2Form 8-K - Current report
2023/11/1406:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1406:01BWEnveric Biosciences Reports Third Quarter 2023 Corporate and..
2023/11/0622:05EDGAR2Form 8-K - Current report
2023/11/0306:29EDGAR2Form 8-K - Current report
2023/10/3121:05EDGAR2Form 8-K - Current report
2023/10/3121:00BWEnveric Biosciences Receives Notice of Allowance from USPTO..
2023/10/2021:05EDGAR2Form 8-K - Current report
2023/10/2021:00BWEnveric Biosciences to Present at the Centurion One 5th..
2023/10/1821:05EDGAR2Form 8-K - Current report
2023/10/1821:00BWEnveric Biosciences Initiates GLP Toxicology & Safety..
2023/10/1121:05EDGAR2Form 8-K - Current report


Delayed Upgrade Clock